A clinical trial (RCT) conducted at the Sydney Adventist Hospital tested the safety and efficacy of transcranial light therapy in a cohort of 40 idiopathic Parkinson's patients for a period of 12 weeks. Results showed that approximately 70% of the participants responded to active treatment and improved in all sub-score domains (facial, upper-limb, lower-limb, gait and tremor).
McGee, C.; Liebert, A.; Bicknell, B.; Pang, V.; Isaac, V.; McLachlan, C.S.; Kiat, H.; Herkes, G. A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson’s Disease: Post-Hoc Analysis of Motor Outcomes. J. Clin. Med. 2023, 12, 2846. https://doi.org/ 10.3390/jcm12082846
Further Research:
Herkes G, McGee C, Liebert A, Bicknell B, Isaac V, Kiat H, McLachlan CS. A novel transcranial photobiomodulation device to address motor signs of Parkinson's disease: a parallel randomised feasibility study. EClinicalMedicine. 2023 Dec 1;66:102338. doi: 10.1016/j.eclinm.2023.102338. PMID: 38094162; PMCID: PMC10716000.
Description
Key Details
- We offer free shipping for all orders over $100 USD/GBP or $150 worldwide.
- Otherwise, we add a flat delivery fee of $10-15 depending on your location.
- All prices at checkout are final - including shipping and any applicable duties to your location.
- You can return your product up to 14 days after receiving your order. To see if you're eligible for a return, please read our returns policy.
Shop Your Way
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.